Series B stage medical technology company specializing in image-guided tumor ablation and interventional oncology solutions. The company operates in India, the U.S., and Canada to advance minimally invasive cancer treatments.

FifthPoint has advised the company on the following:

• Guided market expansion and product positioning in international healthcare markets.

• Facilitated strategic partnerships with hospitals, oncology centers, and medical distributors.

• Advised on fundraising strategies to support Series B/C growth and global scaling.

• Supported operational scaling and alignment with regulatory standards for global market entry.